ARCHIVES

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

This article is from The Cancer Letter archive.

Vol. 20 No. 38 | October 7, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

In Brief: Little Doubt That DeVita, Frederickson Will Keep Their Jobs; New DCT Projects May Not Be Funded

March 6, 1981

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

NCI-Approved Clinical Trials

June 25, 2004

In Brief: House, Senate Pass Rescision Bills; NCI Compromise Figure Probably About $10 Million Cut For FY 1981

May 29, 1981

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001